New drug with or without other treatments for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This study tests a new drug, 9MW2821, either alone or with other cancer treatments, for people with advanced solid tumors. The goal is to see if it can shrink or control the cancer and to check its safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You need to have a solid tumor that has come back, spread, or cannot be surgically removed.
- You must be in generally good physical condition (able to do light activity or be fully active).
- You need to have at least one tumor that can be measured on a scan.
- You must have enough tumor tissue available for testing (or be willing to provide a biopsy).
- You cannot have had chemotherapy or radiation within the last 3 weeks before starting the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two new experimental drugs (HRS-4642 and SHR-A2102) given together to people with advanced solid tumors. The goal is to see if the combination is safe and helps shrink tumors or slow their growth.
This trial tests a new drug called 7MW4911 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective, and may be an option if you have a tumor that expresses a certain protein (CDH17).
This study tests a new drug combination (called 9MW2821 with other cancer drugs) for women with advanced gynecological cancers that have not responded to other treatments. The goal is to see if the combination is safe and effective in shrinking tumors.
This trial tests a new drug, 9MW2821 (sometimes with a PD-1 inhibitor), for people with advanced triple-negative breast cancer. It may be an option if you've already tried standard treatments or haven't started any yet.
This trial tests a new drug called XNW29016 for people with advanced cancer that has stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This study tests a new drug (9MW2821) against standard chemotherapy for people with triple-negative breast cancer that has spread or come back after prior treatments. The new drug is designed to target and destroy cancer cells more precisely, potentially offering better outcomes.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.